Scope Fluidics Spolka Akcyjna (WAR:SCP) Other Stockholders Equity: zł23.71 Mil (As of Mar. 2026)


WAR:SCP Scope Fluidics Spolka Akcyjna WAR:SCP
50 GF Score
Price zł122.00
GF Value zł129.17
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna Other Stockholders Equity?

Scope Fluidics Spolka Akcyjna WAR:SCP -0.49% 50 Other Stockholders Equity is zł23.71 Mil as of Mar. 2026. GuruFocus rates WAR:SCP with a GF Score™ of 50/100 and a GF Value™ of zł129.17 (Fairly Valued). The stock has 4 warning signs investors should review.

Scope Fluidics Spolka Akcyjna's Other Stockholders Equity for the quarter that ended in Mar. 2026 was zł23.71 Mil.

Scope Fluidics Spolka Akcyjna's quarterly Other Stockholders Equity declined from Sep. 2025 (zł23.71 Mil) to Dec. 2025 (zł23.71 Mil) but then stayed the same from Dec. 2025 (zł23.71 Mil) to Mar. 2026 (zł23.71 Mil).

Scope Fluidics Spolka Akcyjna's annual Other Stockholders Equity declined from Dec. 2023 (zł23.71 Mil) to Dec. 2024 (zł23.71 Mil) and declined from Dec. 2024 (zł23.71 Mil) to Dec. 2025 (zł23.71 Mil).

Scope Fluidics Spolka Akcyjna Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Scope Fluidics Spolka Akcyjna's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scope Fluidics Spolka Akcyjna Other Stockholders Equity Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 23.71 23.71 23.71

Scope Fluidics Spolka Akcyjna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.71 23.71 23.71 23.71 23.71
WAR:SCP
50GF Score
Scope Fluidics Spolka Akcyjna WAR:SCP
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scope Fluidics Spolka Akcyjna Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of zł23.71 Mil mean?
Scope Fluidics Spolka Akcyjna (WAR:SCP) has a Other Stockholders Equity of zł23.71 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Scope Fluidics Spolka Akcyjna and its competitors.
Is Scope Fluidics Spolka Akcyjna's Other Stockholders Equity too high?
Scope Fluidics Spolka Akcyjna's current Other Stockholders Equity is zł23.71 Mil. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Other Stockholders Equity compare to TMO and DHR?
Scope Fluidics Spolka Akcyjna's Other Stockholders Equity of zł23.71 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. Scope Fluidics Spolka Akcyjna's current Other Stockholders Equity is zł23.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna (WAR:SCP) is currently considered Fairly Valued. The stock's GF Value™ is zł129.17, compared to a current price of zł122.00 — trading 5.6% below its estimated fair value. The current Other Stockholders Equity is zł23.71 Mil. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (WAR:SCP), the current Other Stockholders Equity is zł23.71 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (WAR:SCP) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued. The current stock price of zł122.00 is trading 5.6% below its estimated GF Value™ of zł129.17. GuruFocus considers Scope Fluidics Spolka Akcyjna to be Fairly Valued.

Key valuation signals for WAR:SCP:

  • Other Stockholders Equity: zł23.71 Mil
  • GF Value™: zł129.17 vs. price of zł122.00 (5.6% below fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the WAR:SCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scope Fluidics Spolka Akcyjna Business Description

Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
50GF Score

Get the complete analysis for WAR:SCP

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł122.00
Price
zł129.17
GF Value